Search Results 251-260 of 16839 for Linaclotide

  1. Aclidinium and formoterol (inhalation route) - Side effects & dosage - Mayo Clinic

    Aclidinium and formoterol combination is used as maintenance treatment in patients with chronic obstructive pulmonary disease (COPD). It will not relieve a COPD ...

  2. Fosnetupitant/palonosetron (intravenous route) - Side effects & uses - Mayo Clinic

    Fosnetupitant and palonosetron combination injection is used together with dexamethasone to prevent nausea and vomiting that is caused by cancer medicines ( ...

  3. Publications - Layne M. Bettini, M.D., J.D. - Mayo Clinic

    Pai SL, Nimma SR, Beam WB, VanderWielen BA, Kalagara HK, Bettini LM, Yu S, Sharpe EE, Harbell MW. Assessment of Gastric Content Using Gastric Ultrasound in ...

  4. Clinical trials - Oncology (Medical)

    The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

  5. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  6. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...

  7. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

  8. Paricalcitol (oral route) - Side effects & dosage - Mayo Clinic

    Paricalcitol is used to treat and prevent hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition ...

  9. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  10. A Study to Validate Bowel Diaries in Healthy Participants and Participants with Fecal Incontinence - Mayo Clinic

    This study will validate a bowel diary to be used for a forthcoming study comparing effectiveness of biofeedback, sacral nerve stimulation, and injectable ...